Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 17
Publications (10 Years): 17
Publications
- Isabel Nogueira, Martí Català, Andrew D White, Sally A Sharpe, Jordi Bechini, Clara Prats, Cristina Vilaplana, Pere Joan Cardona
- Isabel Nogueira, Martí Català, Andrew D White, Sally A Sharpe, Jordi Bechini, Clara Prats, Cristina Vilaplana, Pere Joan Cardona
- Isabel Nogueira, Martí Català, Andrew D White, Sally A Sharpe, Jordi Bechini, Clara Prats, Cristina Vilaplana, Pere Joan Cardona
- Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja, Nestani Tukvadze, Tamta Korinteli, Tumelo Moloantoa, Kaori L Fonseca, Natasha Pillay, Thabiso Seiphetlo, Dan Ouchi-Vernet, Adrian Siles, Lidia Carabias, Carles Quiñones, Sergo Vashakidze, Neil Martinson, Cristina VilaplanaSMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials 24 (1) (2023)
- Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja, Nestani Tukvadze, Tamta Korinteli, Tumelo Moloantoa, Kaori L Fonseca, Natasha Pillay, Thabiso Seiphetlo, Dan Ouchi-Vernet, Adrian Siles, Lidia Carabias, Carles Quiñones, Sergo Vashakidze, Neil Martinson, Cristina VilaplanaSMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials 24 (1) (2023)
- Isabel Nogueira, Martí Català, Andrew D White, Sally A Sharpe, Jordi Bechini, Clara Prats, Cristina Vilaplana, Pere Joan Cardona
- Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja, Nestani Tukvadze, Tamta Korinteli, Tumelo Moloantoa, Kaori L Fonseca, Natasha Pillay, Thabiso Seiphetlo, Dan Ouchi-Vernet, Adrian Siles, Lidia Carabias, Carles Quiñones, Sergo Vashakidze, Neil Martinson, Cristina VilaplanaSMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials 24 (1) (2023)
- Pablo Soldevilla, Cristina Vilaplana, Pere Joan Cardona
- Pablo Soldevilla, Cristina Vilaplana, Pere Joan Cardona
- Solomon Tibebu Melkie, Lilibeth Arias, Chiara Farroni, Mateja Jankovic Makek, Delia Goletti, Cristina Vilaplana
- Pablo Soldevilla, Cristina Vilaplana, Pere Joan Cardona
- Pablo Soldevilla, Cristina Vilaplana, Pere Joan Cardona
- Miguel Moreno-Molina, Natalia Shubladze, Iza Khurtsilava, Zaza Avaliani, Nino Bablishvili, Manuela Torres-Puente, Luis Villamayor, Andrei Gabrielian, Alex Rosenthal, Cristina Vilaplana, Sébastien Gagneux, Russell R Kempker, Sergo Vashakidze, Iñaki Comas
- Judith Farrés, Jose Luis Ruiz, Jose Manuel Mas, Lilibeth Arias, Maria-Rosa Sarrias, Carolina Armengol, Pere-Joan Cardona, Jose A Munoz-Moreno, Miriam Vilaplana, Belen Arranz, Judith Usall, Antoni Serrano-Blanco, Cristina Vilaplana
- Lúcia Moreira-Teixeira, Philippa J Stimpson, Evangelos Stavropoulos, Sabelo Hadebe, Probir Chakravarty, Marianna Ioannou, Iker Valle Aramburu, Eleanor Herbert, Simon Lawrence Priestnall, Alejandro Suarez-Bonnet, Jeremy Sousa, Kaori L Fonseca, Qian Wang, Sergo Vashakidze, Paula Rodríguez-Martínez, Cristina Vilaplana, Margarida Saraiva, Venizelos Papayannopoulos, Anne O'Garra
- Pau Benito, Sergo Vashakidze, Shota Gogishvili, Keti Nikolaishvili, Albert Despuig, Nestan Tukvadze, Natalia Shubladze, Zaza Avaliani, Cristina Vilaplana
- Martí Català, Jordi Bechini, Montserrat Tenesa, Ricardo Pérez, Mariano Moya, Cristina Vilaplana, Joaquim Valls, Sergio Alonso Muñoz, Daniel López, Pere Joan Cardona, Clara Prats